MLchartDataset catalogue

MVA-BN smallpox vaccine

Term · Oncology and biomedicine · MLC-T-ONC-015379

A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-015379
FieldOncology and biomedicine
Synonymsmodified vaccinia Ankara - Bavarian Nordic smallpox vaccine; modified vaccinia Ankara smallpox vaccine; MVA smallpox vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015379",
  "term": "MVA-BN smallpox vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis.",
  "synonyms": [
    "modified vaccinia Ankara - Bavarian Nordic smallpox vaccine",
    "modified vaccinia Ankara smallpox vaccine",
    "MVA smallpox vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mva-bn-smallpox-vaccine/"
}

Record 11,474 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.